Celgene Corporation
$88.9M 60,850 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. reported $88,597,173.74 across General Payments, Research, and Ownership to 33,496 physicians and teaching hospitals across 34,372 transactions.
- $88.6M
- All-tracks total
- 34,372
- Transactions
- 33,496
- Recipients
- −$44.6M
- General Payments vs PY2023
Zimmer Biomet Holdings, Inc. reported $88,597,173.74 across all CMS Open Payments tracks (General + Research + Ownership) to 33,496 physicians and teaching hospitals in Program Year 2024 - ranking #32 of 1,925 reporting manufacturers (0.6% of the all-tracks industry total); General Payments alone were $83,904,351.23, averaging $2.6K per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer zimmer-biomet-holdings-inc Zimmer Biomet Holdings, Inc.
$88.6M · #32/1,925 · 0.6% industry · PY2024
- TOT $88.6M
- RANK #32
- SHARE 0.6%
- TXN 34,372
- RCP 33,496
- CAT 11
- GEN $83.9M
- ΔGEN −$44.6M
- TOP1 29.8%
- PY 2024
Volume peers
Nearest volume peer: Celgene Corporation ($88.9M)
Zimmer Biomet Holdings, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Zimmer Biomet Holdings, Inc.'s CMS-reported General Payments decreased by $44.6M (−34.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ZIMMER BIOMET HOLDINGS, INC.PY2023: ZIMMER BIOMET HOLDINGS, INC.PY2024: Zimmer Biomet Holdings, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $128,468,493.70
- PY2024
- $83,904,351.23
What the Data Shows for Zimmer Biomet Holdings, Inc.
In Program Year 2024, Zimmer Biomet Holdings, Inc. reported $88,597,173.74 in payments to 33,496 physicians and teaching hospitals across 34,372 individual transactions, an average of $2.6K per transaction and $2.6K per recipient. That total places Zimmer Biomet Holdings, Inc. at rank #32 out of 1,925 companies in the CMS Open Payments database, representing 0.6% of all industry payments reported nationwide for the year.
"Acquisitions" leads the 11-category general-payment breakdown below at $40.1M (47.8% of General Payments, 56 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Acquisitions" leads Zimmer Biomet Holdings, Inc.'s 11-category general-payment breakdown at $40.1M, 47.8% of the reported total.
Zimmer Biomet Holdings, Inc. reports 11 general-payment categories - the top three are Acquisitions (47.8%), Royalty or License (33.3%), and Education (7.6%). The remaining 8 categories make up 11.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Zimmer Biomet Holdings, Inc. files across 11 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Zimmer Biomet Holdings, Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Acquisitions | $40.1M | 56 | 47.8% |
| Royalty or License | $27.9M | 647 | 33.3% |
| Education | $6.4M | 2,924 | 7.6% |
| Consulting Fee | $4.8M | 1,736 | 5.8% |
| Travel and Lodging | $2.2M | 8,808 | 2.6% |
| Food and Beverage | $1.4M | 18,994 | 1.7% |
| Space Rental or Facility Fees | $349.3K | 41 | 0.4% |
| Debt Forgiveness | $264.1K | 160 | 0.3% |
| Compensation for Services Other Than Consulting | $204.3K | 27 | 0.2% |
| Grant | $179.8K | 79 | 0.2% |
| Long-Term Medical Supply or Device Loan | $44.3K | 24 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $40,109,576.00 (47.8%) of $83,904,351.23 in this company's General Payments records across 7,888 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Zimmer Biomet Holdings, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Nitin Goyal
$25,000,264.39 across 6 reported transactions
- 2
Erik Kubiak
$7,390,410.50 across 7 reported transactions
- 3
Colin Poole
$3,199,557.39 across 2 reported transactions
- 4
Aaron Hofmann
$2,593,980.00 across 1 reported transactions
- 5
Jonathan Yerasimides
$1,925,363.72 across 181 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Zimmer Biomet Holdings, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Zimmer Biomet Holdings, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Zimmer Biomet Holdings, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
CSL Behring
$88.2M 27,644 recipients
Compare payment profiles
Abbott Laboratories
$91.7M 292,558 recipients
Compare payment profiles
Incyte Corporation
$84.4M 77,737 recipients
Compare payment profiles
Edwards Lifesciences Corporation
$93.0M 70,149 recipients
Compare payment profiles
Servier BioInnovation
$83.4M 11 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.